TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05911256

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pharmacist Only
Description: Clinical pharmacists conduct encounters with patients by videoconferencing or phone. Pharmacists conduct a broad range of activities including ongoing evaluation of medication and lifestyle adherence, setting therapeutic goals, formulating a provider-approved plan of care, and documenting the plan in the electronic health record. Pharmacists propose medication changes based on algorithms and protocols derived from national guidelines under physician guidance.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pharmacist Only
Description: Clinical pharmacists conduct encounters with patients by videoconferencing or phone. Pharmacists conduct a broad range of activities including ongoing evaluation of medication and lifestyle adherence, setting therapeutic goals, formulating a provider-approved plan of care, and documenting the plan in the electronic health record. Pharmacists propose medication changes based on algorithms and protocols derived from national guidelines under physician guidance.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pharmacist Only
Description: Clinical pharmacists conduct encounters with patients by videoconferencing or phone. Pharmacists conduct a broad range of activities including ongoing evaluation of medication and lifestyle adherence, setting therapeutic goals, formulating a provider-approved plan of care, and documenting the plan in the electronic health record. Pharmacists propose medication changes based on algorithms and protocols derived from national guidelines under physician guidance.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitor (CGM)
Description: Patients will receive the Continuous Glucose Monitoring (CGM) system. The instruction on use of device is the intervention being tested, not the effectiveness of the device itself. Participants will receive instruction and training on how to use the device and will wear the device for 14 days.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitor (CGM)
Description: Patients will receive the Continuous Glucose Monitoring (CGM) system. The instruction on use of device is the intervention being tested, not the effectiveness of the device itself. Participants will receive instruction and training on how to use the device and will wear the device for 14 days.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW)
Description: Patients are connected to a community health worker(CHW). CHWs conduct home visits and facilitate 3-way Telehealth visits (Patients, pharmacists, and CHWs) via an iPad with cellular plan. Additional CHW activities include social determinants of health screening, health behavior education, problem solving, goal setting, and medication adherence support.
Study: NCT05929911

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trauma-focused psychodynamic psychotherapy
Description: This psychotherapy addresses disruptions in the ability to reflect and affective regulation by exploring the psychological meanings of symptoms and their relation to traumatic events. The therapist works to identify intrapsychic conflicts, intense negative affects, and defense mechanisms related to the PTSD syndrome using a psychodynamic formulation that provides a framework for intervention. The transference provides a forum for patients to address feelings of mistrust, difficulties with authority, fears of abuse, angry and guilty feelings, and fantasies.~This treatment will be provided in-person or over teletherapy as the public health situation demands.
Study: NCT05746793

Intervention type: DIAGNOSTIC_TEST
Intervention: Urine collection
Description: Collection of urine in a plastic cup.

Intervention type: DIAGNOSTIC_TEST
Intervention: Urine collection
Description: Collection of urine in a plastic cup.
Study: NCT06087432

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rocabado's 6x6 Exercises
Description: Rocabado's 6x6 program includes 6 basic components: tongue rest position, TMJ rotation control, cervical spine release, shoulder girdle retraction and rhythmic stabilization technique.
Study: NCT05746793

Intervention type: OTHER
Intervention: MOCK frozen embryo transfer preparative cycle.
Description: Start with daily estradiol (progynova, oestrogel) administration at hormonal baseline (day 2 of the cycle or with confirmation using endocrine evaluation). When adequate thickness (≥6.5 mm) of the endometrium is achieved (usually after 10-14 days), progesterone is administered daily. 6 days after progesterone administration, the pipelle biopsy will be performed. When this test cycle has ended and menstruation starts, patients will be asked to collect their menstrual flow, during the first night of heavy/red flow, in a menstrual cup. The next day patients will be asked to bring their collected menstrual blood to our center and they will undergo a blood analysis needed for the start of their ART treatment.

Intervention type: OTHER
Intervention: MOCK frozen embryo transfer preparative cycle.
Description: Start with daily estradiol (progynova, oestrogel) administration at hormonal baseline (day 2 of the cycle or with confirmation using endocrine evaluation). When adequate thickness (≥6.5 mm) of the endometrium is achieved (usually after 10-14 days), progesterone is administered daily. 6 days after progesterone administration, the pipelle biopsy will be performed. When this test cycle has ended and menstruation starts, patients will be asked to collect their menstrual flow, during the first night of heavy/red flow, in a menstrual cup. The next day patients will be asked to bring their collected menstrual blood to our center and they will undergo a blood analysis needed for the start of their ART treatment.

Intervention type: DIAGNOSTIC_TEST
Intervention: Baseline questionnaire
Description: questionnaire the patient has to fill in

Intervention type: DIAGNOSTIC_TEST
Intervention: Baseline questionnaire
Description: questionnaire the patient has to fill in
Study: NCT06087432

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rocabado's 6x6 Exercises
Description: Rocabado's 6x6 program includes 6 basic components: tongue rest position, TMJ rotation control, cervical spine release, shoulder girdle retraction and rhythmic stabilization technique.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PNF Exercises
Description: Proprioceptive neuromuscular facilitation (PNF) exercises will be applied to the neck and jaw with rhythmic stabilization (RS) and combined isotonic contraction (CIC) techniques. The RS protocol consists of alternating isometric contractions for 10 seconds and does not involve movement. The KIK technique involves combined concentric, isometric and eccentric contraction of the agonist muscle without rest, with each contraction lasting 5 seconds. KIK exercises consist of 5-15 repetitions per set, depending on the individual's tolerance. Between sets, a 30-second rest will be included. First, the RS protocol will be applied and after a 2-minute rest interval, the exercise will continue with the KIK protocol applications. The expected duration of exercise exercises is 30 minutes. Maximum performance will be requested from the individual in all repetitions and the necessary verbal commands will be given for appropriate movement.
Study: NCT06629441

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic group
Description: taking 10 billion CFU probiotic one sachet one time, lasting 56 days.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo group
Description: taking maltodaxtrin one sachet one time, lasting 56 days.
Study: NCT05746793

Intervention type: OTHER
Intervention: collection of menstrual blood
Description: collection of menstrual blood during the first day of heavy menstrual flow for at least 6 hours

Intervention type: OTHER
Intervention: collection of menstrual blood
Description: collection of menstrual blood during the first day of heavy menstrual flow for at least 6 hours

Intervention type: DIAGNOSTIC_TEST
Intervention: nutritional and metabolic work-up
Description: Including body composition analysis by BIA/whole body MRI and analysis of resting energy expenditure (REE).

Intervention type: DIAGNOSTIC_TEST
Intervention: nutritional and metabolic work-up
Description: Including body composition analysis by BIA/whole body MRI and analysis of resting energy expenditure (REE).

Intervention type: DIAGNOSTIC_TEST
Intervention: cardiac work-up
Description: Using transthoracic ultrasound.

Intervention type: DIAGNOSTIC_TEST
Intervention: cardiac work-up
Description: Using transthoracic ultrasound.

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood pressure measurement
Description: Blood pressure measurement
Study: NCT06629675

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Music walking application BeatClearWalker (BCW)
Description: The music walking application (BCW) is a smartphone application that can monitor the walking pace and allow individuals to listen to music and give immediate feedback so they can correct their walking pace to match their target walking speed, as prescribed by the healthcare professional. The application provides real-time audio feedback in the form of music; the music sound quality will reduce whenever the walking speed drops below or exceeds the participant\&#39;s target walking speed. Simply, the application will work to supervise service users while exercising walking. The investigators are trying to assess the feasibility of this application with service users during their Pulmonary Rehabilitation programme (at the hospital/ home) to find out how participants interact with listening to music while exercise walking and how well they're able to keep to their target speed.
Study: NCT04621682

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non technical skills and checklist training in simulation
Description: using structured debrifing, in three random medical simulation crises, training in non-technical skills will be carried out

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Checklist training simulation
Description: using structured debrifing, in three random medical simulation crises, training in checklist will be carried out
Study: NCT06321913

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI343 combined with IBI308
Description: IBI343 Specifications: 100 mg/bottle Approval method: TBD Q3W intravenous infusion (IV) sintilimab Specifications: 100mg (10ml)/bottle Afghan way: 200 mg Q3W IV infusion
Study: NCT04648436

Intervention type: OTHER
Group type: OTHER
Intervention: Early neurosurgical hematoma evacuation
Description: Early neurosurgical hematoma evacuation (preferably within 2 hours)

Intervention type: OTHER
Group type: OTHER
Intervention: Conservative treatment (best medical management)
Description: Conservative treatment (best medical management) on the ICU or ward
Study: NCT05478772

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CTP-543
Description: 12 mg on Day 1 and Day 7

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluconazole
Description: 200 mg once daily on Days 3 through to Day 8
Study: NCT05746793

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood pressure measurement
Description: Blood pressure measurement
Study: NCT05436093

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-FDG
Description: All study participants will undergo one 18F-FDG PET/CT scan.
Study: NCT04821115

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low intensity choc waves therapy (active applicator)
Description: At each of the 4 sessions, 4000 shockwaves will be delivered at level 8 (EFD = 0.133 mJ/mm2), over a period of 15 to 20 minutes. The probe will be applied directly to the plaque, on the flaccid penis. The device will stop automatically after the 4000 shock waves.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham (sham applicator)
Description: At each of the 4 sessions, a sham applicator will be used. The sham applicator has an internal foam pad that disperses the shockwave energy, but is not visible from the outside. The sham applicator will look, feel and sound the same as the active, but no measurable energy is emitted.
Study: NCT06306781

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HCL001 cell (homologous allogeneic hepatocytes) injection
Description: The patient will undergo a DSA procedure in the hospital's operating room before infusion. A catheter will be inserted into the femoral artery and guided to the hepatic artery. Upon confirmation through imaging, HCL001 cell injection will be slowly infused through the catheter. During the infusion, the cells should be continuously agitated to prevent clumping. The infusion can be administered as a single dose or multiple doses, and after infusion, the patient will be closely monitored for at least one week.
Study: NCT05638113

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pleural injection of autologous blood
Description: 120 ml autologous blood will be drawn from simple venous puncture and immediately injected through the drain into the pleural cavity followed by flushing with 50ml of saline.
Study: NCT05993884

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: iEPCs
Description: Given: IV

Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Clinical standard treatment (CST)
Description: Clinical standard treatment

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Clinical standard treatment (CST)
Description: Clinical standard treatment
Study: NCT04743011

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Heparin sodium
Description: Nebulized inhalation of 5 mL of a solution containing high molecular weight heparin - enriched heparin - 2.5mg/mL and 0.9% saline solution, every 4 hours for 7 days, except during the nighttime (5 doses/day)
Study: NCT06322459

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sport Education Curriculum
Description: The six characteristics of The Sport Education Model include season, affiliation, formal competition, culminating event, Record-keeping, and Festivity. The intensity of the training is increasing in the first 30 minutes, and the intensity is gradually decreasing in the next 10 minutes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Normal teaching
Description: The intervention content, frequency, and intensity were the same as those in the experimental group, but the type of intervention was different. The most significant difference between the two teaching methods lies in delivering basic content. The Sport Education Model includes Teacher-directed learning (10 minutes) and Team practice (10 minutes); Normal Teaching includes Teacher-directed learning (10 minutes) and Individual practice (10 minutes).
Study: NCT06117943

Intervention type: OTHER
Intervention: data collection
Description: Pregnant women who smoke personally or are passively exposed to cigarette smoke
Study: NCT06412302

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whey Protein+Resistance Training
Description: WP group received 25g protein on one scoop of Whey Protein Isolate (Iso100 Dymatize) with 8 weeks of resistance training 3 days a week.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High protein yogurt+Resistance Training
Description: PY group received 24.6g protein on two High Protein yogurts (Lonco Leche) with 8 weeks of resistance training 3 days a week.
Study: NCT05022563

Intervention type: DRUG
Intervention: Parenteral anticoagulant
Description: Parenteral anticoagulant only

Intervention type: DRUG
Intervention: Warfarin
Description: Warfarin-based

Intervention type: DRUG
Intervention: Apixaban
Description: Apixaban

Intervention type: DRUG
Intervention: Rivaroxaban
Description: Rivaroxaban

Intervention type: DRUG
Intervention: Dabigatran
Description: Dabigatran

Intervention type: DRUG
Intervention: Edoxaban
Description: Edoxaban
Study: NCT05931120

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: dry needling using 50mm or 60mm sized needles based on individual muscle bulk. Targeted dry needling will be performed on the muscles presenting with tight hamstrings. hurdler Hamstring stretch, extended triangular pose 10 repetitions, 3 sets per session and 2 sessions per week for 4weeks.~total 8 sessions , each consisting of 40mins

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IASTM
Description: Instrument assisted soft tissue mobilization tools targeting tight hamstrings. hurdler Hamstring stretch, extended triangular pose 10 repetitions, 3 sets per session and 2 sessions per week for 4weeks.~total 8 sessions , each consisting of 40mins
Study: NCT04923126

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirdametinib
Description: By mouth, nasogastric (NG) tube or gastrostomy tube (G-tube) BID, days 1-28

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirdametinib
Description: By mouth, nasogastric (NG) tube or gastrostomy tube (G-tube) BID, days 1-28

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirdametinib
Description: By mouth, nasogastric (NG) tube or gastrostomy tube (G-tube) BID, days 1-28

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirdametinib
Description: By mouth, nasogastric (NG) tube or gastrostomy tube (G-tube) BID, days 1-28

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirdametinib
Description: By mouth, nasogastric (NG) tube or gastrostomy tube (G-tube) BID, days 1-28
Study: NCT06035484

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Seat height
Description: Seat height of a manual wheelchair will be changed according the different arms specified. The participant will complete a course in the manual wheelchair with each arm.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Seat height
Description: Seat height of a manual wheelchair will be changed according the different arms specified. The participant will complete a course in the manual wheelchair with each arm.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Seat height
Description: Seat height of a manual wheelchair will be changed according the different arms specified. The participant will complete a course in the manual wheelchair with each arm.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Seat height
Description: Seat height of a manual wheelchair will be changed according the different arms specified. The participant will complete a course in the manual wheelchair with each arm.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Seat height
Description: Seat height of a manual wheelchair will be changed according the different arms specified. The participant will complete a course in the manual wheelchair with each arm.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Seat inclination
Description: Seat inclination of a manual wheelchair will be changed according the different arms specified. The participant will complete a course in the manual wheelchair with each arm.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Seat inclination
Description: Seat inclination of a manual wheelchair will be changed according the different arms specified. The participant will complete a course in the manual wheelchair with each arm.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Seat inclination
Description: Seat inclination of a manual wheelchair will be changed according the different arms specified. The participant will complete a course in the manual wheelchair with each arm.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Seat inclination
Description: Seat inclination of a manual wheelchair will be changed according the different arms specified. The participant will complete a course in the manual wheelchair with each arm.
Study: NCT05081336

Intervention type: DRUG
Intervention: Statin
Description: Statin +/- ezetimib +/- Alirocumab

Intervention type: DRUG
Intervention: Statin
Description: Statin +/- ezetimib +/- Alirocumab

Intervention type: DRUG
Intervention: Statin
Description: Statin +/- ezetimib +/- Alirocumab
Study: NCT04838379

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: Ninety patients were randomized to receive ultrasound-guided RSB\&tap block After the induction of anesthesia and patient stabilization, the abdomen was sterilized and draped. Then, under complete aseptic conditions, ultrasound-guided Bilateral Rectus Sheath Block \& tap block was performed

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dexmedetomidine
Description: Ninety patients were randomized to receive ultrasound-guided RSB\&tap block After the induction of anesthesia and patient stabilization, the abdomen was sterilized and draped. Then, under complete aseptic conditions, ultrasound-guided Bilateral Rectus Sheath Block \& tap block was performed

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: Ninety patients were randomized to receive ultrasound-guided RSB\&tap block After the induction of anesthesia and patient stabilization, the abdomen was sterilized and draped. Then, under complete aseptic conditions, ultrasound-guided Bilateral Rectus Sheath Block \& tap block was performed
Study: NCT06412211

Intervention type: DEVICE
Intervention: Photoacoustic finder
Description: Sentinel lymph node detector using photoacoustic signal
Study: NCT05409521

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Description: Kinesio taping with the mechanical correction technique will be applied on the thoracic region

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo taping
Description: Placebo taping with no tension and technique will be applied on the arm
Study: NCT04743011

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Nebulized inhalation of 5 mL of 0.9% saline solution, every 4 hours for 7 days, except during the nighttime (5 doses/day)
Study: NCT05856396

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Triaxis® (Pertussis-containing vaccine)
Description: Triaxis® (Pertussis-containing vaccine) will be administered:~* in non-pregnant women presenting to the Travel and Vaccine clinic for pertussis immunization only or hospital member staff requiring Tetanus Toxoid (TT)-booster immunisation~* in Pregnant women between 16 and 29 weeks of gestation.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Triaxis® (Pertussis-containing vaccine)
Description: Triaxis® (Pertussis-containing vaccine) will be administered:~* in non-pregnant women presenting to the Travel and Vaccine clinic for pertussis immunization only or hospital member staff requiring Tetanus Toxoid (TT)-booster immunisation~* in Pregnant women between 16 and 29 weeks of gestation.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Vaxelis® (Pertussis-containing vaccine)
Description: Vaxelis® (Hexavalent vaccine) will be proposed in infants at 8, 12 and 16 weeks of life.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Vaxelis® (Pertussis-containing vaccine)
Description: Vaxelis® (Hexavalent vaccine) will be proposed in infants at 8, 12 and 16 weeks of life.